Roxithromycin (Biorox DPS) is a semi-synthetic macrolide antibiotic, prescribed for respiratory tract, urinary and soft tissue infections. The information provided on this page is intended to serve as ...
Roxithromycin (Zedan (30 ml)) is a semi-synthetic macrolide antibiotic, prescribed for respiratory tract, urinary and soft tissue infections. The information provided on this page is intended to serve ...
Berlin, Germany - Another study of the macrolide antibiotic roxithromycin in the setting of acute myocardial infarction (AMI) has failed to show a benefit in improving survival or reducing the risk of ...
Munich, Germany - One month's treatment with roxithromycin slowed the progression of atherosclerosis in patients with cerebrovascular disease in a new study. Although no effect on clinical events was ...
Roxithromycin, sometimes known as arrow-roxithromycin, is a semi-synthetic macrolide drug that works by interrupting with protein synthesis to stop bacteria from growing. Conjunctivitis, rhinitis, ...
Growing research activities for expanding applications of roxithromycin is projected to fuel the growth of the roxithromycin market over the forecast period. For instance, according to research by ...